Your browser doesn't support javascript.
A severe refractory COVID-19 patient responding to convalescent plasma; A case series.
Abdullah, Hadi Mohammed; Hama-Ali, Hersh H; Ahmed, Sabah Nasraddin; Ali, Kosar Muhammad; Karadakhy, Kamaran Amin; Mahmood, Safeen Othman; Mahmood, Zana Hameed; Hamad Amin, Karmand Qadir; Atta, Peshnyar Muhammad; Nuradeen, Bryar Ezadeen; Mohammed, Shvan H; Salih, Rawezh Q; Baba, Hiwa O; Kakamad, Fahmi H.
  • Abdullah HM; Shar Hospital, Sulaimani, Kurdistan, Iraq.
  • Hama-Ali HH; Shahid Dr.Hemn Hospital, Sulaimani, Kurdistan, Iraq.
  • Ahmed SN; General Director of Health in Sulaimani, Kurdistan, Iraq.
  • Ali KM; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq.
  • Karadakhy KA; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq.
  • Mahmood SO; College of Medicine, University of Sulaimani, Sulaimani, Kurdistan, Iraq.
  • Mahmood ZH; Molecular Diagnostic Laboratory, Sulaimani Veterinary Directorate, Sulaimani, Kurdistan, Iraq.
  • Hamad Amin KQ; Shahid Dr.Hemn Hospital, Sulaimani, Kurdistan, Iraq.
  • Atta PM; Molecular Diagnostic Laboratory, Sulaimani Veterinary Directorate, Sulaimani, Kurdistan, Iraq.
  • Nuradeen BE; Central Public Health Laboratory, Sulaimani, Kurdistan, Iraq.
  • Mohammed SH; Kscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
  • Salih RQ; Kscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
  • Baba HO; Smart Health Tower, Sulaimani, Kurdistan, Iraq.
  • Kakamad FH; Kscien Organization, Hamdi Str, Azadi Mall, Sulaimani, Kurdistan, Iraq.
Ann Med Surg (Lond) ; 56: 125-127, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-614418
ABSTRACT

INTRODUCTION:

Although some medicines are under research, currently, no specific antiviral drug has been approved to target 2019 novel coronavirus. In this report two severe cases of 2019 novel coronavirus disease (COVID-19) patients have been described who received convalescent plasma (CP). CASE REPORT Two male cases (a 46-year-old and a 56-year-old) after being diagnosed with severe COVID-19, they deteriorated despite supportive care and antiviral therapy. They started to improve with CP infusion both clinically and radiologically. Finally they were discharged in a very well condition with negative virology tests.

CONCLUSION:

CP might be an effective therapy for severe COVID-19 patients.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ann Med Surg (Lond) Year: 2020 Document Type: Article Affiliation country: J.amsu.2020.06.018

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Ann Med Surg (Lond) Year: 2020 Document Type: Article Affiliation country: J.amsu.2020.06.018